Peroxisome prolifreator-activated receptors and neurodegenerative diseases

Chinese Pharmacological Bulletin

Volumn 22, Issue 4, 2006, Pages 397-402

  Zhang, Hui Ling ^a   Gu, Zhen Lun ^a   Qin, Zheng Hong ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Neurodegenerative diseases; Neuroprotection; Nuclear hormone receptors; PPARs

Indexed keywords

HORMONE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL DAMAGE; CELL GROWTH; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DRUG DISTRIBUTION; DRUG MECHANISM; MULTIPLE SCLEROSIS; NEUROPROTECTION; PARKINSON DISEASE;

EID: 33745434203     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sundvold H, Iien S. Identification of a novel peroxisome proliferator activated receptor (PPARγ) gamma promotor in man and transactivation by the nuclear receptor ROR alpha1[J]. Biochem Biophys Res Commun, 2001, 287(2):383-90.
2. Deplanque D, Gelé P, Pétrault O, et al. Peroxisome proliferators-activated receptor-αactivation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment[J]. Neuroscience, 2003, 23(1):6264-71.
3. Inoue H, Jiang X F, Katayama T, et al. Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferators-activated receptorain mice[J]. Neuroscience Letters, 2003, 352:203-6.
4. Farioli-Vecchioli S, Moreno S, Ceru M P. Immunocytochemical localization of acyl-CoA oxidase in the rat central nervous system [J]. J Neurocytol, 2001, 30:21-33.
5. Issemann I, Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators[J]. Nature, 1990, 347(6294):645-50.
6. Combs C K, Johnson D E, Karlo J C, et al. Inflammatory mechanisms in Alzheimers disease: Inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists [J]. J Neuroscience, 2000, 20(2):558-67.
7. Wang Y J, He F, Li X L. The neuroprotection of resveratrol in the experimental cerebral ischemia[J]. Zhonghua Yi Xue Za Zhi, 2003, 83(7):534-6.
8. Svenningsson P, Fienberg A A, Allen P B, et al. Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32 [J]. J Neurochem, 2000, 75:248-57.
9. Kim E J, Kwon K J, Park J Y, et al. Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: Associated with iNOS and COX-2[J]. Brain. Res, 2002, 941:1-10.
10. Moreno S, Farioli-Vecchioli S, Ceru M P. Immunolocalization of peroxisome proliferator-activated receptors and retinoid x receptors in the adult rat CNS[J]. Neuroscience, 2004, 123(1):131-45.
11. 2 inhibits multiple steps in the NF-κB signaling pathway[J]. PNAS, 2000, 97:4844-9.
12. Kitamura Y, Shimohama S, Koike H, et al. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimers disease brains[J]. Biochem Biophys Res Commun, 1999, 252:582-6.
13. 2 represses nitric oxide, TNF-α, and IL-12 production by microglial cells[J]. J Neuroimmunol, 2001, 115:28 -35.
14. 1 response and experimental allergic encephalomyelitis[J]. J Immunol, 2003, 171(11):5743-50.
15. 2 a-meliorates experimental autoimmune encephalomyelitis[J]. J Immunol, 2002, 168(5):2508-15.
16. Feinstein D L, Galea E, Gavrilyuk V, et al. Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis[J]. Ann Neurol, 2002, 51(6):694-702.
17. Rossi A, Kapahi P, Natoli G, et al. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase[J]. Nature, 2000, 403:103-8.
18. 2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial Cells[J]. Metabolism, 2001, 50:3-11.